» Authors » T C Wilcosky

T C Wilcosky

Explore the profile of T C Wilcosky including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 448
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Inskip P, Tarone R, Hatch E, Wilcosky T, Shapiro W, Selker R, et al.
N Engl J Med . 2001 Jan; 344(2):79-86. PMID: 11150357
Background: Concern has arisen that the use of hand-held cellular telephones might cause brain tumors. If such a risk does exist, the matter would be of considerable public health importance,...
2.
Hoerger T, Bala M, Bray J, Wilcosky T, LaRosa J
Am J Cardiol . 1998 Jul; 82(1):61-5. PMID: 9671010
To estimate the fraction of United States (U.S.) adults who are eligible for treatment to reduce elevated low-density lipoprotein (LDL) cholesterol levels based on Adult Treatment Panel II (ATP II)...
3.
Markowitz N, Hansen N, Hopewell P, Glassroth J, Kvale P, Mangura B, et al.
Ann Intern Med . 1997 Jan; 126(2):123-32. PMID: 9005746
Background: The resurgence of tuberculosis in the United States is largely linked to the human immunodeficiency virus (HIV) epidemic. Despite this link, the epidemiology of tuberculosis and preventive strategies in...
4.
Millard P, Wilcosky T, Weber D
West J Med . 1996 Jun; 164(6):486-91. PMID: 8764622
To describe the clinical and demographic characteristics of fatal hepatitis due to single-drug isoniazid preventive therapy for tuberculosis, we did a survey of cases from state health departments, published case...
5.
Mumford J, Williams K, Wilcosky T, Everson R, Young T, Santella R
Mutat Res . 1996 Apr; 359(3):171-7. PMID: 8618549
Human exposure to polycyclic aromatic hydrocarbons (PAHs) has been determined by measurement of DNA adducts in human tissues. Competitive enzyme-linked immunosorbent assays (ELISAs) using antisera recognizing benzo[a]pyrenediol-epoxide-modified DNA (BPDE-I-DNA) and...
6.
Hirschtick R, Glassroth J, Jordan M, Wilcosky T, Wallace J, Kvale P, et al.
N Engl J Med . 1995 Sep; 333(13):845-51. PMID: 7651475
Background: Patients with human immunodeficiency virus (HIV) infection are at increased risk for bacterial pneumonia in addition to opportunistic infection. However, the risk factors for bacterial pneumonia and its incidence...
7.
Wilcosky T
Environ Health Perspect . 1993 Dec; 101 Suppl 4:193-7. PMID: 8206030
Biological markers of intermediate health outcomes sometimes provide a superior alternative to traditional measures of pollutant-related disease. Some opportunities and methodologic issues associated with using markers are discussed in the...
8.
Markowitz N, Hansen N, Wilcosky T, Hopewell P, Glassroth J, Kvale P, et al.
Ann Intern Med . 1993 Aug; 119(3):185-93. PMID: 8100692
Objective: To determine the prevalence and predictors of reactivity to tuberculin purified protein derivative (PPD) and skin test anergy in patients with human immunodeficiency virus (HIV) infection and in HIV-seronegative...
9.
Wilcosky T
Epidemiology . 1993 Jan; 4(1):87-8. PMID: 8420589
No abstract available.
10.
Kritchevsky S, Wilcosky T, Morris D, Truong K, Tyroler H
Cancer Res . 1991 Jun; 51(12):3198-203. PMID: 2039996
Changes in lipoprotein cholesterol, total plasma cholesterol, and weight prior to the diagnosis of cancer were examined in 103 men who developed cancer in a cohort of 3805 type IIa...